ResearcherUniversity of CincinnatiActive in the last 2 years
Harold W. Davis
Matched on OpenAlex author ID A5112202091. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. Co-author DOI 10.3390/cancers17071224↗
- Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual or combination therapy for pancreatic ca… Co-author DOI 10.4251/wjgo.v13.i6.550↗
- Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. First author DOI 10.1016/j.ymthe.2020.05.013↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaoyang Qi · 3 shared papers, 2020–2025 · strength 0.52
- Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
- Paper Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual … DOI 10.4251/wjgo.v13.i6.550↗
- Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
- Ahmet Kaynak · 2 shared papers, 2021–2025 · strength 0.41
- Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
- Paper Targeting of elevated cell surface phosphatidylserine with saposin C-dioleoylphosphatidylserine nanodrug as individual … DOI 10.4251/wjgo.v13.i6.550↗
- Clayton S. Lewis · 2 shared papers, 2020–2025 · strength 0.33
- Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
- Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
- Vladimir Y. Bogdanov · 2 shared papers, 2020–2025 · strength 0.33
- Paper Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer. DOI 10.3390/cancers17071224↗
- Paper Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. DOI 10.1016/j.ymthe.2020.05.013↗
- Petr Müller · 1 shared paper, 2025 · strength 0.22
- Kombo F. N’Guessan · 1 shared paper, 2020 · strength 0.11
- Syed Ameen Ahmad · 1 shared paper, 2020 · strength 0.11
- Zhengtao Chu · 1 shared paper, 2020 · strength 0.11
- Jen Jen Yeh · 1 shared paper, 2020 · strength 0.11
- Olugbenga Olanrele Olowokure · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.